Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Diagnostic Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Barrett Esophagus 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Lung Diseases 1 Hypoxia 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Breast Neoplasms 1 Breast Neoplasm Female 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Cisplatin 203 Radiotherapy 150 Cetuximab 115 pembrolizumab 96 Fluorouracil 78 Docetaxel 76 Paclitaxel 66 Carboplatin 66 Radiotherapy, Intensity-Modulated 59 Nivolumab 33 Radiation 28 Drug Therapy 26 Gemcitabine 22 Gefitinib 19 Erlotinib Hydrochloride 19 Standard of Care 17 Cyclophosphamide 17 durvalumab 16 Surgical Procedures, Operative 16 Magnetic Resonance Spectroscopy 16 Surveys and Questionnaires 15 Pemetrexed 15 atezolizumab 14 Bevacizumab 14 Low-Level Light Therapy 13 Filgrastim 13 Celecoxib 13 Capecitabine 13 Amifostine 13 Radiosurgery 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02478138 2024-04-15

SLN Mapping

University Health Network, Toronto

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡